Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection
Condition(s):Pulmonary Infection; Covid-19Last Updated:September 23, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Pulmonary Infection; Covid-19Last Updated:September 23, 2021Terminated
Condition(s):HealthyLast Updated:September 16, 2009Completed
Condition(s):Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis, Secondary Progressive; Multiple Sclerosis, Primary ProgressiveLast Updated:February 12, 2018Completed
Condition(s):Quality of Life; DepressionLast Updated:September 19, 2007Completed
Condition(s):Hyperhidrosis; Compensatory Sweating; Compensatory HyperhidrosisLast Updated:January 22, 2021Completed
Condition(s):Advanced Solid TumorLast Updated:May 9, 2023Recruiting
Condition(s):Non-thyroidal Illness SyndromeLast Updated:July 24, 2012Completed
Condition(s):Congenital Heart DefectsLast Updated:July 19, 2018Unknown status
Condition(s):FibromyalgiaLast Updated:July 14, 2017Completed
Condition(s):Partial Edentulism; Tooth DiseaseLast Updated:March 29, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.